DE
EN
Epidemiology, pathogenesis and diagnostic challenges
Feline herpesvirus (FHV-1) belongs to the Herpesviridae family and is one of the most common infections in cats worldwide. It causes a wide range of clinical signs, including respiratory problems, conjunctivitis and other ophthalmological diseases.
Epidemiology of FHV-1
FHV-1 spreads mainly through direct contact with infected cats or their secretions. Transmission can also occur indirectly via contaminated surfaces. The disease affects cats of all ages and is particularly prevalent in multi-cat households, animal shelters and breeding facilities.
Pathogenesis of FHV-1
FHV-1 enters through the mucous membranes of the respiratory tract and/or eyes and infects the epithelial cells there. The virus replicates and spreads in the infected tissues. The cat's immune response leads to inflammation and tissue damage, which causes the clinical symptoms.
Feline herpesvirus (FHV-1) can cause a variety of clinical signs in infected cats. The most common clinical signs include:
Respiratory symptoms:
- Sneezing
- Nasal discharge (watery or purulent)
- Stuffy nose
- Cough
- Difficulty breathing
- Weakened appetite due to reduced sense of smell
Ophthalmological symptoms:
- Conjunctivitis (inflammation of the conjunctiva) with redness and swelling of the eyes
- Eye discharge (watery, purulent or serous)
- Blepharospasm (spasmodic squinting of the eyelids)
- Corneal ulcers (often with a cloudy appearance)
- Sensitivity to light (photophobia)
- Loss of visual acuity
It is important to note that the clinical signs of FHV-1 can vary from cat to cat. Some cats may only show mild symptoms, while others may develop more severe disease. In addition, the virus can go into a latent state in some cats, where they show no obvious symptoms but still carry the virus and can be reactivated in stressful situations.
It is advisable to consult a vet if FHV-1 infection is suspected in order to obtain an accurate diagnosis and initiate appropriate treatment.
Diagnosis of FHV-1
The diagnosis of FHV-1 infection is based on a combination of clinical signs, laboratory tests and virus detection methods such as PCR, virus isolation or serological tests. The interpretation of diagnostic results can be challenging as both acute and latent infections need to be considered.
Treatment and prevention
Treatment of FHV-1 includes symptomatic therapy, such as relief of respiratory symptoms and treatment of eye problems. Antiviral drugs can be used in some cases to inhibit viral replication. Prevention includes vaccination programmes, hygiene measures and minimising stress to reduce the activation of latent infections.
Expert knowledge
L-lysine, an essential amino acid, is often used to support the health of cats with herpes virus infection. L-lysine has several modes of action that can help alleviate the symptoms of the infection and promote recovery.
- Inhibition of virus replication: L-lysine works by blocking the arginine transporter, which is essential for the replication of the herpes virus. Through this inhibition, L-lysine can reduce the replication of the virus and thus slow down the progression of the infection.
- Supporting the immune system: L-lysine can strengthen the immune system by promoting the production of antiviral substances and antibodies. This helps to improve the cat's immune response against the herpes virus and fight the infection more effectively.
- Reduction of symptoms: L-lysine can help to reduce the intensity and duration of clinical symptoms such as respiratory problems and eye inflammation. By alleviating these symptoms, L-lysine can improve the cat's general well-being.
It is important to note that L-lysine alone is not a cure for herpes virus infection in cats, but is a supportive measure. It should be administered in consultation with a veterinarian who will determine the correct dosage and duration of treatment based on the cat's individual condition.
Challenges and future perspectives
Controlling FHV-1 remains a challenge due to the persistence of the virus, high prevalence and limited effectiveness of some treatment approaches. Advances in vaccine development, antiviral therapy, and infection control are critical to reducing the impact of FHV-1 on cat populations.
